Literature DB >> 9472894

Low molecular weight iron in cerebral ischemic acidosis in vivo.

D C Lipscomb1, L G Gorman, R J Traystman, P D Hurn.   

Abstract

BACKGROUND AND
PURPOSE: Iron-catalyzed radical generation is a potentially significant mechanism by which extensive tissue acidosis exacerbates brain injury during ischemia/reperfusion. We hypothesized that levels of low-molecular-weight (LMW) iron increase during in vivo global cerebral ischemia in a pH-dependent manner, potentially catalyzing oxidant injury. The present study quantified regional differences in LMW iron during global cerebral incomplete ischemia and determined whether augmenting the fall in ischemic tissue pH with hyperglycemia also amplifies free iron availability.
METHODS: Dogs anesthetized with pentobarbital-fentanyl were treated with 30 minutes of global incomplete cerebral ischemia produced by intracranial pressure elevation. Cerebral energy metabolites (ATP, phosphocreatine) and intracellular pH (pHi) were measured by 31P magnetic resonance spectroscopy. Preischemic plasma glucose level was manipulated to titrate end-ischemic pHi. After ischemia, brains were perfused with cold phosphate-buffered saline solution; then 16 different brain areas were sampled, filtered to separate the LMW fraction (<30000 D), and assayed by rapid colorimetric assay for tissue iron. Total iron, LMW iron, and protein in each sample were measured in sham-operated (no ischemia, n=8), normoglycemic ischemia (ISCH [glucose 7+/-4 mmol/L], n=7), and hyperglycemic (GLU-ISCH [glucose 31+/-3 mmol/L], n=9) groups.
RESULTS: High-energy phosphates fell to near zero values in both ISCH and GLU-ISCH groups by 30 minutes but remained unchanged in the sham-operated group. As expected, pHi decreased during ischemia but to a greater extent in GLU-ISCH (6.20+/-0.05 in ISCH, 6.08+/-0.04 in GLU-ISCH, P<.05). Iron could be detected in all areas of the brain in sham-operated animals, with the highest amounts obtained from subcortical areas such as the hippocampus, pons, midbrain, and medulla. Total iron was higher in ISCH relative to sham-operated animals and higher in cortex and pons relative to GLU-ISCH. Regional LMW (as a percentage of total iron; LMW/total iron) was elevated in numerous brain areas in ISCH, including cortical gray matter, cerebellum, hippocampus, caudate, and midbrain. LMW/total iron was higher in GLU-ISCH versus ISCH in cortical gray matter only. In other brain areas, ischemic LMW/total iron was equivalent in glucose-treated or normoglycemic animals (white matter, thalamus, pons, medulla) or lower in the glucose-treated group (cerebellum, hippocampus, caudate, midbrain).
CONCLUSIONS: These data demonstrate that levels of total and LMW iron increase with global cerebral ischemia in the majority of cortical and subcortical regions of normoglycemic brain. However, exacerbation of ischemic acidosis via glucose administration does not increase tissue iron and produces a greater increase in the LMW fraction in cortical gray matter only. In other brain regions, total and LMW iron availability is similar to that of nonischemic animals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472894     DOI: 10.1161/01.str.29.2.487

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  27 in total

1.  Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia.

Authors:  Glenda M Bishop; Theresa N Dang; Ralf Dringen; Stephen R Robinson
Journal:  Neurotox Res       Date:  2010-04-30       Impact factor: 3.911

2.  The physiological behaviour of IMR-32 neuroblastoma cells is affected by a 12-h hypoxia/24-h reoxygenation period.

Authors:  Carlo Aldinucci; Silvia Maria Maiorca; Paola De Rosa; Mitri Palmi; Claudia Sticozzi; Lucia Ciccoli; Silvia Leoncini; Cinzia Signorini; Giuseppe Valacchi; Gian Paolo Pessina
Journal:  Neurochem Res       Date:  2010-07-18       Impact factor: 3.996

3.  Specific Inhibition of NEIL-initiated repair of oxidized base damage in human genome by copper and iron: potential etiological linkage to neurodegenerative diseases.

Authors:  Muralidhar L Hegde; Pavana M Hegde; Luis M F Holthauzen; Tapas K Hazra; K S Jagannatha Rao; Sankar Mitra
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

Review 4.  Role of iron in ischemia-induced neurodegeneration: mechanisms and insights.

Authors:  Gillipsie Minhas; Shweta Modgil; Akshay Anand
Journal:  Metab Brain Dis       Date:  2014-03-11       Impact factor: 3.584

5.  Synergistic accumulation of iron and zinc by cultured astrocytes.

Authors:  Glenda M Bishop; Ivo F Scheiber; Ralf Dringen; Stephen R Robinson
Journal:  J Neural Transm (Vienna)       Date:  2010-06-12       Impact factor: 3.575

6.  Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin.

Authors:  K Zaman; H Ryu; D Hall; K O'Donovan; K I Lin; M P Miller; J C Marquis; J M Baraban; G L Semenza; R R Ratan
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

7.  The functional role of hemojuvelin in acute ischemic stroke.

Authors:  Guang-Huar Young; Sung-Chun Tang; Vin-Cent Wu; Kuo-Chuan Wang; Jing-Yi Nong; Po-Yuan Huang; Chaur-Jong Hu; Hung-Yi Chiou; Jiann-Shing Jeng; Chung Y Hsu
Journal:  J Cereb Blood Flow Metab       Date:  2019-07-15       Impact factor: 6.200

Review 8.  Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders.

Authors:  P J Syapin
Journal:  Br J Pharmacol       Date:  2008-09-15       Impact factor: 8.739

Review 9.  Janus-faced tumor microenvironment and redox.

Authors:  Valery V Khramtsov; Robert J Gillies
Journal:  Antioxid Redox Signal       Date:  2014-03-04       Impact factor: 8.401

10.  The effects of hypoxia/reoxygenation on the physiological behaviour of U373-MG astrocytes.

Authors:  Carlo Aldinucci; Silvia Maria Maiorca; Paola De Rosa; Mitri Palmi; Claudia Sticozzi; Lucia Ciccoli; Silvia Leoncini; Cinzia Signorini; Gian Paolo Pessina
Journal:  Neurochem Res       Date:  2009-07-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.